Home > Products > CD33 & CD16
> Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (CrossMab)
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (CrossMab) (CAT#: CROSSAB-114)
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (CrossMab) (CROSSAB-114). Click the button below to contact us or submit your feedback about this product.